CD9 and breast carcinoma: We isolated TDEs from E0771 breast cancer cell supernatant and validated their identity by CD9, CD63, and GAPDH expression, nanoparticle tracking analysis (NTA), and transmission electron microscopy (TEM) (Fig. S2A–D).